HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Caporossi, D. Articles by Bacchetti, S. Search for Related Content PubMed PubMed Citation Articles by Caporossi, D. Articles by Bacchetti, S. Agricola Articles by Caporossi, D. Articles by Bacchetti, S.

Definition of adenovirus type 5 functions involved in the induction of chromosomal aberrations in human cells

Daniela Caporossi

Molecular Virology and Immunology Programme, Department of Pathology, McMaster University, Hamilton, Ontario L8N 3Z5, Canada

Infection of human embryonic kidney cells with adenovirus type 5 (Ad5) induces aberrations (gaps and breaks) in the cell chromosomes. We have conducted a study utilizing a large number of Ad5 mutants to identify the viral functions that are responsible for the occurrence of cytogenetic damage. The results of our investigation have indicated that expression of the gene products of the Ad5 early region 1A (E1A) is necessary for the induction of chromosomal aberrations and that other early viral gene products do not appear to contribute to this phenotype. We have also shown that expression of both the major E1A gene products, the 243 amino acid and the 289 amino acid proteins, is required for induction of damage at wild-type levels, although the 289 amino acid protein appears to retain detectable activity on its own. Lastly, we have observed that deletions in the amino-terminal region of the E1A proteins and in the transactivating domain of the 289 amino acid protein prevent the occurrence of cytogenetic damage, whereas mutations elsewhere in the proteins do not affect this process.

Present address: Department of Public Health, University of Rome II, Italy.

Received 4 September 1989; accepted 13 December 1989.

This article has been cited by other articles:

				A. De Luca, R. Mangiacasale, A. Severino, L. Malquori, A. Baldi, A. Palena, A. M. Mileo, P. Lavia, and M. G. Paggi E1A Deregulates the Centrosome Cycle in a Ran GTPase-dependent Manner Cancer Res., March 15, 2003; 63(6): 1430 - 1437. [Abstract] [Full Text] [PDF]

				M. Nevels, B. Täuber, T. Spruss, H. Wolf, and T. Dobner "Hit-and-Run" Transformation by Adenovirus Oncogenes J. Virol., April 1, 2001; 75(7): 3089 - 3094. [Abstract] [Full Text]

				A. L. Kung, V. I. Rebel, R. T. Bronson, L.-E. Ch'ng, C. A. Sieff, D. M. Livingston, and T.-P. Yao Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP Genes & Dev., February 1, 2000; 14(3): 272 - 277. [Abstract] [Full Text]

				M Debbas and E White Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes & Dev., April 1, 1993; 7(4): 546 - 554. [Abstract] [PDF]